{
    "SPADE_UN_26540": {
        "Sequence Information": {
            "Peptide Name": "Brevinin-1pl [A16Del]",
            "Sequence": "FFPKVAGVAAKVLKKFCTISKKC",
            "Sequence Length": 23,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer\n2. DNA / RNA",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Discovery, development and optimisation of a novel frog antimicrobial peptide with combined mode of action against drug-resistant bacteria",
                    "Pubmed ID": "39345903",
                    "Reference": "Comput Struct Biotechnol J. 2024;23:3391-3406",
                    "Author": "Wang J, Hu J, Pu W, Chen X, Ma C, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, Wang L",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39345903"
                }
            ],
            "Mass": 2514.15,
            "PI": 10.05,
            "Net Charge": 6,
            "Hydrophobicity": 0.56,
            "Frequent Amino Acids": "KAF",
            "Absent Amino Acids": "DEHMNOQRUWY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 13,
            "Polar Residues": 10,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26540",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_14455",
                    "Similarity": 1.0,
                    "Sequence": "FFPKVAGVAAKVLKKIFCTISKKC"
                },
                {
                    "SPADE_ID": "SPADE_N_14457",
                    "Similarity": 1.0,
                    "Sequence": "FFPKVAGVAAKVLKKAFCTISKKC"
                },
                {
                    "SPADE_ID": "SPADE_N_14460",
                    "Similarity": 1.0,
                    "Sequence": "FFPKVAGVAAKVKKFCTISKKC"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:10% Hemolysis=>128 µM,Horse erythrocytes:50% Hemolysis=>128 µM,Human keratinocytes HaCat:IC50=128.1 µM",
            "Target Organism": "Staphylococcus aureus ATCC 6538(MIC=32µM),Staphylococcus aureus ATCC 6538(MBC=32µM),Staphylococcus aureus NCTC 12493(MIC=>128µM),Enterococcus faecalis NCTC 12697(MIC=64µM),Enterococcus faecalis NCTC 12697(MBC=>128µM),Klebsiella pneumoniae ATCC 43816(MIC=4µM),Klebsiella pneumoniae ATCC 43816(MBC=8µM),Pseudomonas aeruginosa ATCC 9027(MIC=16µM),Pseudomonas aeruginosa ATCC 27853(MBC=16µM),Acinetobacter baumannii ATCC BAA-747(MIC=16µM),Acinetobacter baumannii ATCC BAA-747(MBC=16µM),Candida albicans ATCC 10231(MIC=16µM),Candida albicans ATCC 10231(MBC=32µM),Escherichia coli ATCC 8739(MIC=2µM),Escherichia coli ATCC 8739(MIC=4µM),Escherichia coli ATCC 8739(MIC=8µM),Escherichia coli ATCC 8739(MIC=32µM),Escherichia coli ATCC 8739(MBC=2µM),Escherichia coli NCTC 13846(MIC=4µM),Escherichia coli NCTC 13846(MIC=8µM),Escherichia coli NCTC 13846(MIC=64µM),Escherichia coli NCTC 13846(MIC=16µM),Escherichia coli ATCC BAA-2340(MIC=4µM),Escherichia coli ATCC BAA-2340(MIC=2µM),Escherichia coli ATCC BAA-2340(MIC=16µM),Escherichia coli ATCC BAA-2340(MIC=8µM),Escherichia coli ATCC BAA-2340(MBC=4µM),Human lung adenocarcinoma NCI-H838(IC50=4.536µM),Human breast adenocarcinoma MCF-7(IC50=7.194µM)"
        }
    }
}